Loading…

Humanized, Nonmitogenic OKT3 Antibody, huOKT3γ(Ala-Ala): Initial Clinical Experience

Saved in:

Bibliographic Details
Published in:	Transplantation proceedings 1998-06, Vol.30 (4), p.1369-1370
Main Authors:	Woodle, E.S., Bluestone, J.A., Zivin, R.A., Jolliffe, L.K., Auger, J., Xu, D., Thistlethwaite, J.R.
Format:	Article
Language:	English
Subjects:	Biological and medical sciences Female Follow-Up Studies Graft Rejection - therapy Humans Immunomodulators Immunosuppressive Agents - pharmacokinetics Immunosuppressive Agents - therapeutic use Kidney Transplantation - immunology Male Medical sciences Muromonab-CD3 - adverse effects Muromonab-CD3 - pharmacokinetics Muromonab-CD3 - therapeutic use Pancreas Transplantation - immunology Pharmacology. Drug treatments Time Factors
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!